| Literature DB >> 27213922 |
Jing Fan1,2,3, Qianjun He4, Yi Liu2, Fuwu Zhang2, Xiangyu Yang1,2, Zhe Wang2, Nan Lu2, Wenpei Fan2,4, Lisen Lin2, Gang Niu2, Nongyue He1, Jibin Song2, Xiaoyuan Chen2.
Abstract
Multidrug resistance (MDR) is responsible for the relatively low effectiveness of chemotherapeutics. Herein, a nitric oxide (NO) gas-enhanced chemosensitization strategy is proposed to overcome MDR by construction of a biodegradable nanomedicine formula based on BNN6/DOX coloaded monomethoxy(polyethylene glycol)-poly(lactic-co-glycolic acid) (mPEG-PLGA). On one hand, the nanomedicine features high biocompatibility due to the high density of PEG and biodegradable PLGA. On the other hand, the nanoformula exhibits excellent stability under physiological conditions but exhibits stimuli-responsive decomposition of BNN6 for NO gas release upon ultraviolet-visible irradiation. More importantly, after NO release is triggered, gas molecules are generated that break the nanoparticle shell and lead to the release of doxorubicin. Furthermore, NO was demonstrated to reverse the MDR of tumor cells and enhance the chemosensitization for doxorubicin therapy.Entities:
Keywords: chemotherapy; light-responsive; mPEG-PLGA; multidrug resistance (MDR); nitric oxide (NO)
Mesh:
Substances:
Year: 2016 PMID: 27213922 PMCID: PMC5233726 DOI: 10.1021/acsami.6b03737
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229